Dr. Liebman on the Use of Digital Surveillance in Melanoma

Video

In Partnership With:

Tracey Liebman, MD, discusses the use of digital surveillance in melanoma.

Tracey Liebman, MD, assistant professor, Ronald O. Perelman Department of Dermatology, NYU Langone School of Medicine, NYU Langone Health, discusses the use of digital surveillance in melanoma.

Digital surveillance has widespread utility in melanoma, says Liebman. For example, patients who have atypical nevi will undergo total body photography. These images can be monitored over time to help identify melanomas and reduce biopsies for normal moles.

Additionally, dermoscopic monitoring through sequential digital dermoscopy imaging can be used to determine whether a biopsy should be done. If there are any short-term changes in the dermoscopic close-up image, a biopsy should be performed, says Liebman; this can diagnose melanoma at a very early stage, Liebman concludes.

Related Videos
Katrina S. Pedersen, MD, MS, associate professor, John T. Milliken Department of Medicine, Division of Oncology, Medical Oncology program leader, cofounder, Young Onset Colorectal Cancer Program, Washington University School of Medicine in St. Louis, Siteman Cancer Center
Debu Tripathy, MD
Changchun Deng, MD, PhD
Joaquim Bellmunt, MD, PhD
Timothy Yap, MBBS, PhD, FRCP
Parul N Barry, MD,
Ramez Kouzy, MD, MD Anderson
Bernard A. Fox, PhD
Bradley R. Corr, MD, associate professor, LeBert Suess Family Endowed Professor in Ovarian Cancer Research, gynecologic oncology team, the University of Colorado Anschutz Medical Campus